Target intelligence / Profile preview

Cupressus arizonica allergen 1 (Cup a 1) - Immunoglobulin E (IgE) - High affinity immunoglobulin epsilon receptor (FcεRI) complex (Cup a 1-IgE-FcεRI)

Target
Cup a 1-IgE-FcεRI
Molecular classification
Pectate lyase, Allergen, Immunoglobulin-receptor complex
01

Overview

Cupressus arizonica allergen 1 (Cup a 1) is the primary pectate lyase allergen found in the pollen of the Arizona cypress, a major cause of winter pollinosis in Mediterranean and semi-arid regions (UniProt P80174, IUIS Allergen Nomenclature). The target "Cup a 1 – IgE on mast cells/basophils" describes the functional complex formed when Cup a 1 molecules cross-link specific IgE antibodies that are anchored to the high-affinity IgE receptor (FcεRI) on the surface of mast cells and basophils (PubMed PMID: 7522144). This cross-linking event triggers a signal transduction cascade leading to the degranulation of these effector cells and the subsequent release of inflammatory mediators like histamine, which drive the clinical symptoms of allergic rhinitis and asthma (Janeway's Immunobiology). This complex is a focal point for therapeutic intervention; for instance, omalizumab acts by sequestering free IgE to prevent its binding to FcεRI, thereby reducing the density of the complex on cell surfaces (PubMed PMID: 25697467). Additionally, allergen-specific immunotherapy (AIT) utilizes Cup a 1 extracts to desensitize the immune system, promoting the production of IgG4 blocking antibodies and regulatory T cells to inhibit this specific IgE-mediated pathway (PubMed PMID: 30033913).

Other names
Arizona cypress major allergenPectate lyase Cup a 1Cup a 1-IgE-FcεRI complexCupressus arizonica allergen 1
02

Mechanism of action

Inhibition of IgE-FcεRI interaction and induction of allergen-specific immune tolerance.

03

Biological functions

Immune responseDegranulationCellular signalingPectin catabolism
04

Disease associations

Allergic rhinitisAsthmaType I hypersensitivityPollinosis
05

Safety considerations

Potential for anaphylaxis during skin testing or immunotherapyRisk of systemic allergic reactions
06

Interacting drugs

Omalizumab

2 more in the full profile.

07

Biomarkers

Serum specific IgE (sIgE) to Cup a 1Basophil Activation Test (BAT) measuring CD63/CD203cSkin Prick Test (SPT) wheal diameter

Beyond the preview

Go deeper on Cupressus arizonica allergen 1 (Cup a 1) - Immunoglobulin E (IgE) - High affinity immunoglobulin epsilon receptor (FcεRI) complex (Cup a 1-IgE-FcεRI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cupressus arizonica allergen 1 (Cup a 1) - Immunoglobulin E (IgE) - High affinity immunoglobulin epsilon receptor (FcεRI) complex (Cup a 1-IgE-FcεRI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call